business
Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent
MORRISVILLE, N.C., Sept. 30, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, today issued an update regarding the litigation filed by United Therapeutics Corporation (UTHR) in the U.S. District Court for the District of Delaware (the Court) under the Hatch-Waxman Act concerning U.S. Patent No. 11,826,327 (‘327 patent) and the Company’s
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Why oil is still trading near $100 even though Gulf exports have recovered
businessinsider.com
UK Prime Minister Burnham says Iran 'played a part' in British air base incident
cnbc.com
Piyush Goyal gets a ‘trade minister for life’ tag from US trade chief at G20
timesofindia.indiatimes.com
Trump touts $200 billion South Korean investment plan as Alaska LNG project hangs in balance
cnbc.com
Cornell rape case: Prosecutor says he wasn't given transcript of Jane Doe's interview with campus police; university agrees to independent investigation, New York governor says
yahoo.com